Journal profile · Biochemistry, Genetics and Molecular Biology-Biochemistry

Tissue Engineering Part B-Reviews

ISSN 1937-3368 · eISSN 1937-3376 · Mary Ann Liebert Inc. · United States

Tissue Engineering Part B-Reviews: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.2; hybrid open access; community-reported acceptance: easy; 60 articles in 2025; indexed in SCIE and Scopus.

Impact factor4.2Latest value listed by LetPub

CAS zoneZone 2 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine

Review time—No reports yet

APC—No source gives fee information

AcceptanceEasyCommunity average

Articles per year602025 · OpenAlex count

Scope

Aims, scope and focus

Tissue Engineering Part B-Reviews is published by Mary Ann Liebert Inc. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Tissue Engineering and Regenerative Medicine, 3D Printing in Biomedical Research and Electrospun Nanofibers in Biomedical Applications, together about 36.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Sage, a leading independent academic publisher, has acquired Mary Ann Liebert, Inc., a global media company known for publishing over 100 peer-reviewed journals in biotechnology, life sciences, clinical medicine, public health, and engineering. The journals will be available on the Sage Journals platform beginning 1 January 2026. A dual access period will run from 1 January through 30 March 2026

From the journal's Aims & Scope

Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Biochemistry

Main research topics OpenAlex counts of recent articles; shares are approximate

Tissue Engineering and Regenerative MedicineMedicine14.3%
3D Printing in Biomedical ResearchEngineering11.1%
Electrospun Nanofibers in Biomedical ApplicationsMaterials Science10.9%
Bone Tissue Engineering MaterialsEngineering9.3%
Mesenchymal stem cell researchMedicine9%
Periodontal Regeneration and TreatmentsMedicine6%
Osteoarthritis Treatment and MechanismsMedicine5.9%
Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology4.1%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2

Level	Category	Zone
Major	Medicine	Zone 2
Minor	Engineering, Biomedical	Zone 2
Minor	Materials Science, Biomaterials	Zone 2
Minor	Cell & Tissue Engineering	Zone 3
Minor	Cell Biology	Zone 3

Top journal: noReview journal: yes

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2

Level	Category	Zone
Major	Medicine	Zone 2
Minor	Cell & Tissue Engineering	Zone 3
Minor	Cell Biology	Zone 3
Minor	Engineering, Biomedical	Zone 3
Minor	Materials Science, Biomaterials	Zone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2

Level	Category	Zone
Major	Medicine	Zone 2
Minor	Cell & Tissue Engineering	Zone 3
Minor	Cell Biology	Zone 3
Minor	Engineering, Biomedical	Zone 3
Minor	Materials Science, Biomaterials	Zone 3

Top journal: noReview journal: yes

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor: 4.2LetPub · 2026-09-13
CiteScore 2026-06: 13.5LetPub · 2026-09-13
SJR 2026-06: 1.16LetPub · 2026-09-13
SNIP 2026-06: 1.19LetPub · 2026-09-13
h-index: 78LetPub · 2026-09-13
h-index: 135OpenAlex · 2026-10-01
i10-index: 666OpenAlex · 2026-10-01
2-year mean citedness: 3.65OpenAlex · 2026-10-01
Self-citation rate: 2.3%LetPub · 2026-09-13
Share of gold OA articles: 6.59%LetPub · 2026-09-13

Volume

Articles per year: 62LetPub · 2026-09-13

Articles by year OpenAlex count · 911 in total · the current year is incomplete

Year	Articles	Open access	Citations
2026	56	5	26
2025	60	6	167
2024	48	13	406
2023	55	10	627
2022	33	11	682
2021	62	30	2,086

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average acceptance (community reports): EasyLetPub · 2026-09-13

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher: Mary Ann Liebert Inc.
Country or region: United States
Language: English
ISSN: 1937-3368
Electronic ISSN: 1937-3376
Official links: Journal homepage ↗LetPub
Submission system ↗LetPub

FAQ

Frequently asked questions about Tissue Engineering Part B-Reviews

What CAS zone is Tissue Engineering Part B-Reviews in?

In the 2025 upgraded edition of the CAS Journal Ranking, Tissue Engineering Part B-Reviews is in Zone 2 of Medicine, and in Zone 2 of the minor category Engineering, Biomedical / Materials Science, Biomaterials / Cell & Tissue Engineering / Cell Biology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Tissue Engineering Part B-Reviews?

The latest impact factor listed by LetPub is 4.2; CiteScore 13.5, h-index 135.

Which databases index Tissue Engineering Part B-Reviews?

According to LetPub and DOAJ records, Tissue Engineering Part B-Reviews is indexed in SCIE and Scopus.

Is Tissue Engineering Part B-Reviews open access, and what is the APC?

Tissue Engineering Part B-Reviews is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: 2026-10-01.